CureVac | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
16:25 ET
CureVac | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
16:21 ET
CureVac | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 16 16:21 ET
CureVac | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 12 16:53 ET
CureVac | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 4 16:18 ET
CureVac | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(1.2%),Peter Kolchinsky(1.2%), etc.
Feb 14 17:32 ET
CureVac | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-GSK plc(7.4%)
Feb 6 17:13 ET
CureVac | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 17 00:00 ET
CureVac | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 5 00:00 ET
CureVac | 144: Notice of proposed sale of securities pursuant to Rule 144
Jan 5 00:00 ET
CureVac | 144: Notice of proposed sale of securities pursuant to Rule 144
Jan 5 00:00 ET
CureVac | 144: Notice of proposed sale of securities pursuant to Rule 144
Jan 5 00:00 ET
CureVac | 144: Notice of proposed sale of securities pursuant to Rule 144
Jan 5 00:00 ET
CureVac | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 19, 2023 16:30 ET
CureVac | 6-K: Report of foreign private issuer (related to financial reporting)
Nov 14, 2023 16:15 ET
CureVac | 6-K: Report of foreign private issuer (related to financial reporting)
Nov 14, 2023 16:15 ET
CureVac | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Nov 1, 2023 16:45 ET
CureVac | UPLOAD: Others
Oct 19, 2023 15:36 ET
CureVac | 20-F/A: Registration statement / Annual report / Transition report (Amendment)
Oct 12, 2023 16:15 ET
CureVac | CORRESP: CORRESP
Oct 10, 2023 16:15 ET
No Data
No Data